Nu Skin Enterprises Inc. (NYSE:NUS) Receives Average Recommendation of “Hold” from Analysts
Shares of Nu Skin Enterprises Inc. (NYSE:NUS) have earned a consensus recommendation of “Hold” from the twelve analysts that are covering the stock. Two equities research analysts have rated the stock with a sell recommendation, four have issued a hold recommendation, four have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price objective among analysts that have covered the stock in the last year is $50.72.
NUS has been the subject of several recent research reports. Pivotal Research boosted their target price on shares of Nu Skin Enterprises from $55.00 to $60.00 and gave the stock a “buy” rating in a research report on Thursday, June 16th. Jefferies Group restated a “hold” rating and set a $41.00 price target on shares of Nu Skin Enterprises in a report on Friday, June 17th. Zacks Investment Research upgraded shares of Nu Skin Enterprises from a “hold” rating to a “strong-buy” rating and set a $52.00 price target on the stock in a report on Tuesday, June 21st. Citigroup Inc. boosted their price target on shares of Nu Skin Enterprises from $45.00 to $52.00 and gave the stock a “buy” rating in a report on Friday, July 1st. Finally, Deutsche Bank AG restated a “hold” rating and set a $55.00 price target (up from $45.00) on shares of Nu Skin Enterprises in a report on Sunday, July 24th.
In other news, Director Andrew D. Lipman sold 30,000 shares of the business’s stock in a transaction that occurred on Thursday, September 22nd. The shares were sold at an average price of $64.13, for a total value of $1,923,900.00. Following the sale, the director now owns 36,090 shares of the company’s stock, valued at $2,314,451.70. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 4.60% of the stock is currently owned by insiders.
Hedge funds have recently bought and sold shares of the stock. Washington Trust Bank raised its stake in Nu Skin Enterprises by 0.6% in the third quarter. Washington Trust Bank now owns 2,011 shares of the company’s stock valued at $130,000 after buying an additional 11 shares during the period. Metropolitan Life Insurance Co. NY raised its stake in Nu Skin Enterprises by 3.4% in the second quarter. Metropolitan Life Insurance Co. NY now owns 2,349 shares of the company’s stock valued at $109,000 after buying an additional 77 shares during the period. First Quadrant L P CA raised its stake in Nu Skin Enterprises by 0.5% in the second quarter. First Quadrant L P CA now owns 23,323 shares of the company’s stock valued at $1,077,000 after buying an additional 123 shares during the period. Amalgamated Bank raised its stake in Nu Skin Enterprises by 6.0% in the second quarter. Amalgamated Bank now owns 7,263 shares of the company’s stock valued at $423,000 after buying an additional 414 shares during the period. Finally, Paragon Capital Management Ltd raised its stake in Nu Skin Enterprises by 5.5% in the second quarter. Paragon Capital Management Ltd now owns 8,392 shares of the company’s stock valued at $388,000 after buying an additional 441 shares during the period. 77.08% of the stock is currently owned by institutional investors.
Shares of Nu Skin Enterprises (NYSE:NUS) traded down 0.33% during midday trading on Thursday, reaching $65.50. 306,476 shares of the company traded hands. Nu Skin Enterprises has a 12-month low of $23.51 and a 12-month high of $66.04. The company has a 50-day moving average of $60.40 and a 200 day moving average of $48.02. The firm has a market capitalization of $3.66 billion, a PE ratio of 37.58 and a beta of 1.84.
Nu Skin Enterprises (NYSE:NUS) last posted its earnings results on Thursday, August 4th. The company reported $0.79 EPS for the quarter, topping the consensus estimate of $0.78 by $0.01. The company earned $600.05 million during the quarter, compared to the consensus estimate of $578.87 million. Nu Skin Enterprises had a net margin of 4.52% and a return on equity of 18.46%. The firm’s revenue for the quarter was up 7.2% on a year-over-year basis. During the same period in the previous year, the firm posted $0.75 earnings per share. On average, equities analysts forecast that Nu Skin Enterprises will post $2.88 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 14th. Stockholders of record on Friday, August 26th were given a $0.355 dividend. This represents a $1.42 annualized dividend and a dividend yield of 2.16%. The ex-dividend date of this dividend was Wednesday, August 24th. Nu Skin Enterprises’s dividend payout ratio (DPR) is currently 81.14%.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care system and ageLOC Tru Face Essence Ultra anti-aging skin care serum.
Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.